PALO ALTO, Calif., June 30, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has entered into an agreement to sell seven million shares of its common stock to Seaside 88, LP ("Seaside"), a private investment partnership, at a price of $0.865 per share, which represents a 12.6% discount to the closing price per share of June 29. No warrants will be issued in this offering. The offering is expected to close on June 30, 2010, subject to customary closing conditions.
